Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 4
2007 2
2008 2
2010 6
2011 1
2012 5
2013 2
2014 10
2015 6
2016 10
2017 12
2018 16
2019 7
2020 8
2021 7
2022 8
2023 5
2024 5
2025 8
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
Ciardiello D, Martini G, Boscolo Bielo L, Pietrantonio F, Raimondi A, Manca P, Pisconti S, Nisi C, Tortora G, Salvatore L, Sartore-Bianchi A, Siena S, Blasi L, Ongaro E, Zaniboni A, Pinto C, Antonuzzo L, Avallone A, Normanno N, Santabarbara G, Zampino MG, Berardi R, Cogoni A, Lotesoriere C, Latiano TP, Maiello E, Fazio N, Curigliano G, Bordonaro R, Troiani T, De Vita F, Martinelli E, Ciardiello F, Napolitano S; CAVE-2 GOIM study group. Ciardiello D, et al. Among authors: pisconti s. Ann Oncol. 2026 May;37(5):675-685. doi: 10.1016/j.annonc.2025.12.014. Epub 2025 Dec 22. Ann Oncol. 2026. PMID: 41443411 Free article. Clinical Trial.
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.
Prelaj A, Provenzano L, Miskovic V, Ganzinelli M, Mazzeo L, Gemelli M, Silvestri C, Spagnoletti A, Romanò R, Brambilla M, Occhipinti M, Beninato T, Ambrosini P, Sottotetti E, Favali M, Zec A, Ferrarin A, Corrao G, Prina MM, Ruggirello M, Marino MB, Dumitrascu AD, Di Mauro RM, Giani C, Cavalli C, Serino R, Catania C, Panzardi A, Metro G, Bennati C, Ferrara R, Macerelli M, Servetto A, Cona MS, La Verde N, Toschi L, Baili P, Corso F, Zito E, Cinieri S, Berardi R, Scoazec G, Inno A, Gori S, Pisconti S, Buzzacchino F, Brighenti M, Biello F, Tartarone A, Pruneri G, Belfiore A, Agnelli L, Guidi A, Invernizzi L, Salmistraro N, Filippi AR, Solli P, Galli G, Lorenzini D, Pizzutilo EG, De Braud F, Pedrocchi A, Trovò F, Genova C, Corte CMD, Viscardi G, Garassino MC, Cortellini A, Mingo E, Russano M, Signorelli D, Proto C, Vingiani A, Sangaletti S, Lo Russo G; APOLLO11 study group. Prelaj A, et al. Among authors: pisconti s. NPJ Precis Oncol. 2026 Jan 29;10(1):96. doi: 10.1038/s41698-026-01295-3. NPJ Precis Oncol. 2026. PMID: 41611893 Free PMC article.
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.
Ciardiello D, Boscolo Bielo L, Napolitano S, Cioli E, Latiano TP, De Stefano A, Tamburini E, Ramundo M, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Barruca V, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Normanno N, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: pisconti s. Eur J Cancer. 2025 Aug 26;226:115642. doi: 10.1016/j.ejca.2025.115642. Epub 2025 Jul 12. Eur J Cancer. 2025. PMID: 40669385 Clinical Trial.
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Among authors: pisconti s. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459 Free article.
Immunotherapeutic approaches for hepatocellular carcinoma.
Longo V, Gnoni A, Casadei Gardini A, Pisconti S, Licchetta A, Scartozzi M, Memeo R, Palmieri VO, Aprile G, Santini D, Nardulli P, Silvestris N, Brunetti O. Longo V, et al. Among authors: pisconti s. Oncotarget. 2017 May 16;8(20):33897-33910. doi: 10.18632/oncotarget.15406. Oncotarget. 2017. PMID: 28420805 Free PMC article. Review.
Management of recurrent nasopharyngeal carcinoma: current perspectives.
Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M, Pisconti S, Solla R. Perri F, et al. Among authors: pisconti s. Onco Targets Ther. 2019 Feb 26;12:1583-1591. doi: 10.2147/OTT.S188148. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881013 Free PMC article. Review.
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.
Ciardiello D, Boscolo Bielo L, Pietrantonio F, Martini G, Troiani T, Martinelli E, Natangelo S, Bosco MF, Pisconti S, Nisi C, Tortora G, Salvatore L, Sartore-Bianchi A, Siena S, Blasi L, Messina M, Ongaro E, Zaniboni A, Pinto C, Antonuzzo L, Avallone A, Normanno N, Santabarbara G, Zampino MG, Berardi R, Cogoni AA, Leo S, Lotesoriere C, Latiano TP, Maiello E, Fazio N, Curigliano G, Bordonaro R, De Vita F, Ciardiello F, Napolitano S. Ciardiello D, et al. Among authors: pisconti s. ESMO Open. 2025 Jul;10(7):105491. doi: 10.1016/j.esmoop.2025.105491. Epub 2025 Jun 23. ESMO Open. 2025. PMID: 40555076 Free PMC article. Clinical Trial.
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.
Boscolo Bielo L, Napolitano S, Avallone A, Pietrantonio F, Bordonaro R, Maiello E, Pisconti S, Tamburini E, Lotesoriere C, Tortora G, Zaniboni A, Blasi L, Antonuzzo L, Berardi R, Tagliaferri P, Cremolini C, Lonardi S, Garufi C, Pinto C, Ongaro E, Santabarbara G, Scartozzi M, De Falco V, De Stefano A, Cardone C, Iacovucci A, Bosco MF, Russo AE, Latiano TP, Nisi C, Messina M, Salmistraro N, Sartore-Bianchi A, Siena S, Zampino MG, Fazio N, Normanno N, Febbraro A, Guerrera LP, Parente P, De Vita F, Martinelli E, Troiani T, Curigliano G, Ciardiello F, Martini G, Ciardiello D. Boscolo Bielo L, et al. Among authors: pisconti s. ESMO Open. 2025 Nov;10(11):105877. doi: 10.1016/j.esmoop.2025.105877. Epub 2025 Oct 28. ESMO Open. 2025. PMID: 41161130 Free PMC article.
Thyroid cancer management: from a suspicious nodule to targeted therapy.
Perri F, Giordano A, Pisconti S, Ionna F, Chiofalo MG, Longo F, Leopardo D, Della Vittoria Scarpati G, Pezzullo L. Perri F, et al. Among authors: pisconti s. Anticancer Drugs. 2018 Jul;29(6):483-490. doi: 10.1097/CAD.0000000000000617. Anticancer Drugs. 2018. PMID: 29649016 Review.
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.
Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D. Longo V, et al. Among authors: pisconti s. Clin Exp Med. 2018 Aug;18(3):319-323. doi: 10.1007/s10238-018-0493-6. Epub 2018 Feb 28. Clin Exp Med. 2018. PMID: 29492715 Review.
120 results